InvestorsObserver
×
News Home

Is CEL-SCI Corporation (CVM) a Winner in the Biotechnology Industry?

Thursday, December 28, 2023 11:35 AM | InvestorsObserver Analysts

Mentioned in this article

Is CEL-SCI Corporation (CVM) a Winner in the Biotechnology Industry?

A rating of 75 puts CEL-SCI Corporation (CVM) near the top of the Biotechnology industry according to InvestorsObserver. CEL-SCI Corporation's score of 75 means it scores higher than 75% of stocks in the industry. CEL-SCI Corporation also received an overall rating of 58, putting it above 58% of all stocks. Biotechnology is ranked 41 out of the 148 industries.

Overall Score - 58
CVM has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on CVM!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With CEL-SCI Corporation Stock Today?

CEL-SCI Corporation (CVM) stock is trading at $3.01 as of 11:24 AM on Thursday, Dec 28, a rise of $0.02, or 0.67% from the previous closing price of $2.99. The stock has traded between $2.95 and $3.15 so far today. Volume today is below average. So far 172,670 shares have traded compared to average volume of 714,673 shares. Click Here to get the full Stock Report for CEL-SCI Corporation stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App